[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Gastric Cancer Drug Sales Market Report Forecast 2017 to 2022

July 2017 | 100 pages | ID: G86971D853CEN
S&P Consulting

US$ 3,040.00 US$ 3,800.00 -20 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Delivery of the Report will take 2-3 working days once order is placed.

The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology developments, types, applications, and the competitive landscape.

The study is a source of reliable data on:
  • Key market segments and sub-segments
  • Evolving market trends and dynamics
  • Changing supply and demand scenarios
  • Quantifying market opportunities through market sizing and market forecasting
  • Tracking current trends/opportunities/challenges
  • Competitive insights
  • Opportunity mapping in terms of technological breakthroughs
This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. Geographies analyzed under this research report include:
United States
China
Europe
Japan

The Major players reported in the market include:

Hoffmann-La Roche
Eli-lilly
Sanofi
Otsuka Holdings
Novartis
Amgen
Boston Biomedical
AROG Pharmaceuticals
ARIAD Pharmaceuticals

Product Segment Analysis:
  • Type 1
  • Type 2
  • Type 3
Application Segment Analysis:
  • Application 1
  • Application 2
  • Application 3
Reasons for Buying this Report
  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth
  • It provides a six-year forecast assessed on the basis of how the market is predicted to grow
  • It helps in understanding the key product segments and their future
  • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
  • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
  • It provides distinctive graphics and exemplified analysis of major market segments
1 GASTRIC CANCER DRUG MARKET OVERVIEW

1.1 Product Overview and Scope of Gastric Cancer Drug
1.2 Classification of Gastric Cancer Drug
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Application of Gastric Cancer Drug
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Gastric Cancer Drug Market States Status and Prospect (2012-2022) by Regions
  1.4.1 United States
  1.4.2 China
  1.4.3 Europe
  1.4.4 Japan
1.5 Global Market Size of Gastric Cancer Drug (2012-2022)
  1.5.1 Global Gastric Cancer Drug Sales and Growth Rate (2012-2022)
  1.5.2 Global Gastric Cancer Drug Revenue and Growth Rate (2012-2022)

2 GLOBAL ECONOMIC IMPACT ON GASTRIC CANCER DRUG INDUSTRY

2.1 Global Macroeconomic Environment Analysis
  2.1.1 Global Macroeconomic Analysis
  2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions

3 GASTRIC CANCER DRUG MANUFACTURING COST ANALYSIS

3.1 Gastric Cancer Drug Key Raw Materials Analysis
  3.1.1 Key Raw Materials
  3.1.2 Price Trend of Key Raw Materials
  3.1.3 Key Suppliers of Raw Materials
  3.1.4 Market Concentration Rate of Raw Materials
3.2 Proportion of Manufacturing Cost Structure
  3.2.1 Raw Materials
  3.2.2 Labor Cost
  3.2.3 Manufacturing Process Analysis of Gastric Cancer Drug

4 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

4.1 Gastric Cancer Drug Industrial Chain Analysis
4.2 Upstream Raw Materials Sourcing
4.3 Raw Materials Sources of Gastric Cancer Drug Major Manufacturers in 2016
4.4 Downstream Buyers

5 GLOBAL GASTRIC CANCER DRUG COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

5.1 Global Gastric Cancer Drug Market Competition by Manufacturers
  5.1.1 Global Gastric Cancer Drug Sales and Market Share of Key Manufacturers (2012-2017)
  5.1.2 Global Gastric Cancer Drug Revenue and Share by Manufacturers (2012-2017)
5.2 Global Gastric Cancer Drug (Volume and Value) by Type
  5.5.1 Global Gastric Cancer Drug Sales and Market Share by Type (2012-2017)
  5.5.2 Global Gastric Cancer Drug Revenue and Market Share by Type (2012-2017)
5.3 Global Gastric Cancer Drug (Volume and Value) by Regions
  5.3.1 Global Gastric Cancer Drug Sales and Market Share by Regions (2012-2017)
  5.3.2 Global Gastric Cancer Drug Revenue and Market Share by Regions (2012-2017)
5.4 Global Gastric Cancer Drug (Volume) by Application

6 UNITED STATES GASTRIC CANCER DRUG (VOLUME, VALUE AND SALES PRICE)

6.1 United States Gastric Cancer Drug Sales and Value (2012-2017)
  6.1.1 United States Gastric Cancer Drug Sales and Growth Rate (2012-2017)
  6.1.2 United States Gastric Cancer Drug Revenue and Growth Rate (2012-2017)
  6.1.3 United States Gastric Cancer Drug Sales Price Trend (2012-2017)
6.2 United States Gastric Cancer Drug Sales and Market Share by Manufacturers
6.3 United States Gastric Cancer Drug Sales and Market Share by Type
6.4 United States Gastric Cancer Drug Sales and Market Share by Application

7 CHINA GASTRIC CANCER DRUG (VOLUME, VALUE AND SALES PRICE)

7.1 China Gastric Cancer Drug Sales and Value (2012-2017)
  7.1.1 China Gastric Cancer Drug Sales and Growth Rate (2012-2017)
  7.1.2 China Gastric Cancer Drug Revenue and Growth Rate (2012-2017)
  7.1.3 China Gastric Cancer Drug Sales Price Trend (2012-2017)
7.2 China Gastric Cancer Drug Sales and Market Share by Manufacturers
7.3 China Gastric Cancer Drug Sales and Market Share by Type
7.4 China Gastric Cancer Drug Sales and Market Share by Application

8 EUROPE GASTRIC CANCER DRUG (VOLUME, VALUE AND SALES PRICE)

8.1 Europe Gastric Cancer Drug Sales and Value (2012-2017)
  8.1.1 Europe Gastric Cancer Drug Sales and Growth Rate (2012-2017)
  8.1.2 Europe Gastric Cancer Drug Revenue and Growth Rate (2012-2017)
  8.1.3 Europe Gastric Cancer Drug Sales Price Trend (2012-2017)
8.2 Europe Gastric Cancer Drug Sales and Market Share by Manufacturers
8.3 Europe Gastric Cancer Drug Sales and Market Share by Type
8.4 Europe Gastric Cancer Drug Sales and Market Share by Application

9 JAPAN GASTRIC CANCER DRUG (VOLUME, VALUE AND SALES PRICE)

9.1 Japan Gastric Cancer Drug Sales and Value (2012-2017)
  9.1.1 Japan Gastric Cancer Drug Sales and Growth Rate (2012-2017)
  9.1.2 Japan Gastric Cancer Drug Revenue and Growth Rate (2012-2017)
  9.1.3 Japan Gastric Cancer Drug Sales Price Trend (2012-2017)
9.2 Japan Gastric Cancer Drug Sales and Market Share by Manufacturers
9.3 Japan Gastric Cancer Drug Sales and Market Share by Type
9.4 Japan Gastric Cancer Drug Sales and Market Share by Application

10 GLOBAL GASTRIC CANCER DRUG MANUFACTURERS ANALYSIS

10.1 Hoffmann-La Roche
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Product Type, Application and Specification
  10.1.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Business Overview
10.2 Eli-lilly
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Product Type, Application and Specification
  10.2.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Business Overview
10.3 Sanofi
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Product Type, Application and Specification
  10.3.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Business Overview
10.4 Otsuka Holdings
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Product Type, Application and Specification
  10.4.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Business Overview
10.5 Novartis
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Product Type, Application and Specification
  10.5.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Business Overview
10.6 Amgen
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Product Type, Application and Specification
  10.6.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Business Overview
10.7 Boston Biomedical
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Product Type, Application and Specification
  10.7.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Business Overview
10.8 AROG Pharmaceuticals
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Product Type, Application and Specification
  10.8.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.8.4 Business Overview
10.9 ARIAD Pharmaceuticals
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Product Type, Application and Specification
  10.9.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.9.4 Business Overview

...

11 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

11.1 Marketing Channel
  11.1.1 Direct Marketing
  11.1.2 Indirect Marketing
  11.1.3 Marketing Channel Development Trend
11.2 Market Positioning
  11.2.1 Pricing Strategy
  11.2.2 Brand Strategy
  11.2.3 Target Client
11.3 Distributors/Traders List

12 MARKET EFFECT FACTORS ANALYSIS

12.1 Technology Progress/Risk
  12.1.1 Substitutes Threat
  12.1.2 Technology Progress in Related Industry
12.2 Consumer Needs/Customer Preference Change
12.3 Economic/Political Environmental Change

13 GLOBAL GASTRIC CANCER DRUG MARKET FORECAST (2017-2022)

13.1 Global Gastric Cancer Drug Sales, Revenue Forecast (2017-2022)
13.2 Global Gastric Cancer Drug Sales Forecast by Regions (2017-2022)
13.3 Global Gastric Cancer Drug Sales Forecast by Type (2017-2022)
13.4 Global Gastric Cancer Drug Sales Forecast by Application (2017-2022)

14 APPENDIX

LIST OF TABLES AND FIGURES

Figure Picture of Gastric Cancer Drug
Table Classification of Gastric Cancer Drug
Figure Global Sales Market Share of Gastric Cancer Drug by Type in 2016
Table Applications of Gastric Cancer Drug
Figure Global Sales Market Share of Gastric Cancer Drug by Application in 2016
Figure United States Gastric Cancer Drug Revenue and Growth Rate (2012-2022)
Figure China Gastric Cancer Drug Revenue and Growth Rate (2012-2022)
Figure Europe Gastric Cancer Drug Revenue and Growth Rate (2012-2022)
Figure Japan Gastric Cancer Drug Revenue and Growth Rate (2012-2022)
Figure Global Gastric Cancer Drug Sales and Growth Rate (2012-2022)
Figure Global Gastric Cancer Drug Revenue and Growth Rate (2012-2022)
Table Global Gastric Cancer Drug Sales of Key Manufacturers (2012-2017)
Table Global Gastric Cancer Drug Sales Share by Manufacturers (2012-2017)
Figure 2015 Gastric Cancer Drug Sales Share by Manufacturers
Figure 2016 Gastric Cancer Drug Sales Share by Manufacturers
Table Global Gastric Cancer Drug Revenue by Manufacturers (2012-2017)
Table Global Gastric Cancer Drug Revenue Share by Manufacturers (2012-2017)
Table 2015 Global Gastric Cancer Drug Revenue Share by Manufacturers
Table 2016 Global Gastric Cancer Drug Revenue Share by Manufacturers
Table Global Gastric Cancer Drug Sales and Market Share by Type (2012-2017)
Table Global Gastric Cancer Drug Sales Share by Type (2012-2017)
Figure Sales Market Share of Gastric Cancer Drug by Type (2012-2017)
Figure Global Gastric Cancer Drug Sales Growth Rate by Type (2012-2017)
Table Global Gastric Cancer Drug Revenue and Market Share by Type (2012-2017)
Table Global Gastric Cancer Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Gastric Cancer Drug by Type (2012-2017)
Figure Global Gastric Cancer Drug Revenue Growth Rate by Type (2012-2017)
Table Global Gastric Cancer Drug Sales and Market Share by Regions (2012-2017)
Table Global Gastric Cancer Drug Sales Share by Regions (2012-2017)
Figure Sales Market Share of Gastric Cancer Drug by Regions (2012-2017)
Figure Global Gastric Cancer Drug Sales Growth Rate by Regions (2012-2017)
Table Global Gastric Cancer Drug Revenue and Market Share by Regions (2012-2017)
Table Global Gastric Cancer Drug Revenue Share by Regions (2012-2017)
Figure Revenue Market Share of Gastric Cancer Drug by Regions (2012-2017)
Figure Global Gastric Cancer Drug Revenue Growth Rate by Regions (2012-2017)
Table Global Gastric Cancer Drug Sales and Market Share by Application (2012-2017)
Table Global Gastric Cancer Drug Sales Share by Application (2012-2017)
Figure Sales Market Share of Gastric Cancer Drug by Application (2012-2017)
Figure Global Gastric Cancer Drug Sales Growth Rate by Application (2012-2017)
Figure United States Gastric Cancer Drug Sales and Growth Rate (2012-2017)
Figure United States Gastric Cancer Drug Revenue and Growth Rate (2012-2017)
Figure United States Gastric Cancer Drug Sales Price Trend (2012-2017)
Table United States Gastric Cancer Drug Sales by Manufacturers (2012-2017)
Table United States Gastric Cancer Drug Market Share by Manufacturers (2012-2017)
Table United States Gastric Cancer Drug Sales by Type (2012-2017)
Table United States Gastric Cancer Drug Market Share by Type (2012-2017)
Table United States Gastric Cancer Drug Sales by Application (2012-2017)
Table United States Gastric Cancer Drug Market Share by Application (2012-2017)
Figure China Gastric Cancer Drug Sales and Growth Rate (2012-2017)
Figure China Gastric Cancer Drug Revenue and Growth Rate (2012-2017)
Figure China Gastric Cancer Drug Sales Price Trend (2012-2017)
Table China Gastric Cancer Drug Sales by Manufacturers (2012-2017)
Table China Gastric Cancer Drug Market Share by Manufacturers (2012-2017)
Table China Gastric Cancer Drug Sales by Type (2012-2017)
Table China Gastric Cancer Drug Market Share by Type (2012-2017)
Table China Gastric Cancer Drug Sales by Application (2012-2017)
Table China Gastric Cancer Drug Market Share by Application (2012-2017)
Figure Europe Gastric Cancer Drug Sales and Growth Rate (2012-2017)
Figure Europe Gastric Cancer Drug Revenue and Growth Rate (2012-2017)
Figure Europe Gastric Cancer Drug Sales Price Trend (2012-2017)
Table Europe Gastric Cancer Drug Sales by Manufacturers (2012-2017)
Table Europe Gastric Cancer Drug Market Share by Manufacturers (2012-2017)
Table Europe Gastric Cancer Drug Sales by Type (2012-2017)
Table Europe Gastric Cancer Drug Market Share by Type (2012-2017)
Table Europe Gastric Cancer Drug Sales by Application (2012-2017)
Table Europe Gastric Cancer Drug Market Share by Application (2012-2017)
Figure Japan Gastric Cancer Drug Sales and Growth Rate (2012-2017)
Figure Japan Gastric Cancer Drug Revenue and Growth Rate (2012-2017)
Figure Japan Gastric Cancer Drug Sales Price Trend (2012-2017)
Table Japan Gastric Cancer Drug Sales by Manufacturers (2012-2017)
Table Japan Gastric Cancer Drug Market Share by Manufacturers (2012-2017)
Table Japan Gastric Cancer Drug Sales by Type (2012-2017)
Table Japan Gastric Cancer Drug Market Share by Type (2012-2017)
Table Japan Gastric Cancer Drug Sales by Application (2012-2017)
Table Japan Gastric Cancer Drug Market Share by Application (2012-2017)
Table Hoffmann-La Roche Basic Information List
Table Hoffmann-La Roche Gastric Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Hoffmann-La Roche Gastric Cancer Drug Global Market Share (2012-2017)
Table Eli-lilly Basic Information List
Table Eli-lilly Gastric Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Eli-lilly Gastric Cancer Drug Global Market Share (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Gastric Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Sanofi Gastric Cancer Drug Global Market Share (2012-2017)
Table Otsuka Holdings Basic Information List
Table Otsuka Holdings Gastric Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Otsuka Holdings Gastric Cancer Drug Global Market Share (2012-2017)
Table Novartis Basic Information List
Table Novartis Gastric Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novartis Gastric Cancer Drug Global Market Share (2012-2017)
Table Amgen Basic Information List
Table Amgen Gastric Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Amgen Gastric Cancer Drug Global Market Share (2012-2017)
Table Boston Biomedical Basic Information List
Table Boston Biomedical Gastric Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Boston Biomedical Gastric Cancer Drug Global Market Share (2012-2017)
Table AROG Pharmaceuticals Basic Information List
Table AROG Pharmaceuticals Gastric Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure AROG Pharmaceuticals Gastric Cancer Drug Global Market Share (2012-2017)
Table ARIAD Pharmaceuticals Basic Information List
Table ARIAD Pharmaceuticals Gastric Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure ARIAD Pharmaceuticals Gastric Cancer Drug Global Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Gastric Cancer Drug
Figure Manufacturing Process Analysis of Gastric Cancer Drug
Figure Gastric Cancer Drug Industrial Chain Analysis
Table Raw Materials Sources of Gastric Cancer Drug Major Manufacturers in 2016
Table Major Buyers of Gastric Cancer Drug
Table Distributors/Traders List
Figure Global Gastric Cancer Drug Sales and Growth Rate Forecast (2017-2022)
Figure Global Gastric Cancer Drug Revenue and Growth Rate Forecast (2017-2022)
Table Global Gastric Cancer Drug Sales Forecast by Regions (2017-2022)
Table Global Gastric Cancer Drug Sales Forecast by Type (2017-2022)
Table Global Gastric Cancer Drug Sales Forecast by Application (2017-2022)


More Publications